Ongoing research is exploring new molecular targets and targeted therapies for this challenging disease.
The patient was diagnosed as Acute Myeloid Leukemia (AML) M 1 (according to French–American–British classification ... Thorough search of literature revealed that the first case of circulating MMGK ...
According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...
A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
ICT01 showed tolerable safety and promising clinical activity as a monotherapy and is now being investigated in combination ...
According to researchers at The University of Texas MD Anderson Cancer Center, 80% of patients with previously untreated or ...
19, 2024 /PRNewswire/ -- Lucinity and Sift have announced a partnership, unifying fraud and Anti-Money Laundering (AML) into Lucinity's integrated FinCrime compliance platform for case management ...
The study did not provide ... (55 [53%] of 104). 1 Therefore, reduced venetoclax dose intensity might affect treatment outcomes, including complete remission rates and the duration and depth of ...